EconPapers    
Economics at your fingertips  
 

Poly(imidazolium ester) antibiotic forms intracellular polymer-nucleic acid biomolecular condensates and fight drug-resistant bacteria

Xiaofei Xu, Chiranjeevi Korupalli, Divyanshu Mahajan, Chongyun Tan, Quang Huy Nhat Vu, Loi Thang Pham, Lei Lu, E. Peter Greenberg (), Tram T. Dang () and Mary B. Chan-Park ()
Additional contact information
Xiaofei Xu: Nanyang Technological University
Chiranjeevi Korupalli: Nanyang Technological University
Divyanshu Mahajan: Nanyang Technological University
Chongyun Tan: Nanyang Technological University
Quang Huy Nhat Vu: Nanyang Technological University
Loi Thang Pham: Nanyang Technological University
Lei Lu: Nanyang Technological University
E. Peter Greenberg: University of Washington
Tram T. Dang: Nanyang Technological University
Mary B. Chan-Park: Nanyang Technological University

Nature Communications, 2025, vol. 16, issue 1, 1-17

Abstract: Abstract Drug resistance in bacteria is a major problem that calls for new classes of antimicrobial drugs. We report a biodegradable poly(imidazolium ester) (PIE), P8, with excellent broad-spectrum antibacterial activity, high therapeutic selectivity, and an unexploited mechanism of action. P8, a short oligomer, translocates across bacterial membrane and phase separates with intracellular nucleic acids, forming biomolecular condensates. P8 binds the DNA minor groove and intercalates with DNA, interacting with it via electrostatic and hydrogen-bonding interactions. The phase separation of nucleic acids modulated by P8 inhibits in vitro transcription, thereby impeding translation and potentially leading to cell death. Bacterial cytological profiling indicates that the antimicrobial mechanism of P8 differs from those of conventional antibiotics, though it also suggests that P8 may inhibit RNA synthesis. P8 is safe and effective against drug-resistant bacteria in murine models of systemic, intramuscular, and lung infections. This study shows the great potential of intracellular biomolecular condensate formation for combating drug-resistant bacteria.

Date: 2025
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-64828-7 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-64828-7

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-64828-7

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-12-06
Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-64828-7